Skip to main content
Clinical Trials/NCT02371642
NCT02371642
Unknown
Not Applicable

The Utility of Strain Echocardiography in the Management of Acute Heart Failure

Wayne State University1 site in 1 country120 target enrollmentJanuary 2015
ConditionsHeart Failure

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Wayne State University
Enrollment
120
Locations
1
Primary Endpoint
change in global longitudinal strain (GLS)
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this project is to evaluate the utility of left ventricular strain as part of the assessment of patients in the emergency department with acute heart failure (HF). The central hypothesis of the investigation is that left ventricular strain will prove to be a treatment response variable in patients with acute HF. Patients who are being treated for acute HF with intravenous (IV) vasoactive medications (diuretics, vasodilators, inotropes) will be eligible for enrollment. Patients who give written consent will receive a focused bedside echocardiogram within 30 minutes of the initiation of therapy for acute HF. Images that are captured during this echocardiogram will be interpreted by a blinded cardiologist offline. 23 hours after this initial focused echocardiogram a member of the study team will perform a follow-up focused echocardiogram, capturing the same images that will then be interpreted by a blinded cardiologist offline.

Offline analysis will be performed using a proprietary software package from General Electric called Automated Function Imaging (AFI). The AFI software will be used to calculate longitudinal strain of the left ventricle (LV). Regional and global strain values will be calculated for each focused echocardiogram for each subject. It is our hypothesis that LV strain will demonstrate improvements from the initial echocardiogram to the follow-up echocardiogram, unlike other echocardiographic indices in HF such as LV ejection fraction.

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
January 2017
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mark Favot, MD

Assistant Professor of Emergency Medicine

Wayne State University

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or greater
  • Ability for the patient to provide written informed consent
  • Planned treatment with intravenous (IV) medications (diuretics, vasodilators, inotropes) for acute HF

Exclusion Criteria

  • Need for emergent, resuscitative intervention (e.g., cardiopulmonary resuscitation, endotracheal intubation)
  • Rapid atrial fibrillation or other arrhythmia that requires IV rate or rhythm control
  • Plans for emergent percutaneous coronary intervention (PCI) from the ED
  • Pregnancy
  • Incarceration
  • history of cardiac transplant
  • planned transfer to another institution

Outcomes

Primary Outcomes

change in global longitudinal strain (GLS)

Time Frame: 23 hours

Secondary Outcomes

  • Readmission rate(30 days)

Study Sites (1)

Loading locations...

Similar Trials